Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Structural requirements for the binding of the pituitary adenylate-cyclase-activating peptide to receptors and adenylate-cyclase activation in pancreatic and neuronal membranes.
Gourlet P, Woussen-Colle MC, Robberecht P, de Neef P, Cauvin A, Vandermeers-Piret MC, Vandermeers A, Christophe J. Gourlet P, et al. Among authors: vandermeers piret mc, vandermeers a. Eur J Biochem. 1991 Jan 30;195(2):535-41. doi: 10.1111/j.1432-1033.1991.tb15734.x. Eur J Biochem. 1991. PMID: 1997328 Free article.
Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist.
Robberecht P, Gourlet P, De Neef P, Woussen-Colle MC, Vandermeers-Piret MC, Vandermeers A, Christophe J. Robberecht P, et al. Among authors: vandermeers piret mc, vandermeers a. Eur J Biochem. 1992 Jul 1;207(1):239-46. doi: 10.1111/j.1432-1033.1992.tb17043.x. Eur J Biochem. 1992. PMID: 1321043 Free article.
Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21.
Robberecht P, Gourlet P, De Neef P, Woussen-Colle MC, Vandermeers-Piret MC, Vandermeers A, Christophe J. Robberecht P, et al. Among authors: vandermeers piret mc, vandermeers a. Mol Pharmacol. 1992 Aug;42(2):347-55. Mol Pharmacol. 1992. PMID: 1325033
Antagonistic properties are shifted back to agonistic properties by further N-terminal shortening of pituitary adenylate-cyclase-activating peptides in human neuroblastoma NB-OK-1 cell membranes.
Vandermeers A, Vandenborre S, Hou X, de Neef P, Robberecht P, Vandermeers-Piret MC, Christophe J. Vandermeers A, et al. Among authors: vandermeers piret mc. Eur J Biochem. 1992 Sep 15;208(3):815-9. doi: 10.1111/j.1432-1033.1992.tb17252.x. Eur J Biochem. 1992. PMID: 1327769 Free article.
The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes.
Gourlet P, De Neef P, Woussen-Colle MC, Vandermeers A, Vandermeers-Piret MC, Robberecht P, Christophe J. Gourlet P, et al. Among authors: vandermeers piret mc, vandermeers a. Biochim Biophys Acta. 1991 Jul 22;1066(2):245-51. doi: 10.1016/0005-2736(91)90193-c. Biochim Biophys Acta. 1991. PMID: 1649637
The two forms of the pituitary adenylate cyclase activating polypeptide (PACAP (1-27) and PACAP (1-38)) interact with distinct receptors on rat pancreatic AR 4-2J cell membranes.
Robberecht P, Woussen-Colle MC, De Neef P, Gourlet P, Buscail L, Vandermeers A, Vandermeers-Piret MC, Christophe J. Robberecht P, et al. Among authors: vandermeers piret mc, vandermeers a. FEBS Lett. 1991 Jul 29;286(1-2):133-6. doi: 10.1016/0014-5793(91)80958-6. FEBS Lett. 1991. PMID: 1650711 Free article.
106 results